Calliditas reports strong Q4 growth, eyes future expansion By Investing.com
© Reuters. STOCKHOLM - Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX), a biopharmaceutical firm specializing in uncommon ailments, introduced vital ...
© Reuters. STOCKHOLM - Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX), a biopharmaceutical firm specializing in uncommon ailments, introduced vital ...
Copyright © 2023 Financials Up.
Financials Up is not responsible for the content of external sites.
Copyright © 2023 Financials Up.
Financials Up is not responsible for the content of external sites.